Product Details
| Cat.No. | EDC08055 | Product Name | SNCB Knockout HAP1 Cell Line |
|---|---|---|---|
| Species | Human | Cell Line | HAP1 |
| Cellosaurus ID | CVCL_0F62 | NCBI Gene ID | |
| Cell Line Synonyms | Highly Aggressively Proliferating Immortalized | Gene | |
| Summary |
This gene encodes a member of a small family of proteins that inhibit phospholipase D2 and may function in neuronal plasticity. The encoded protein is abundant in lesions of patients with Alzheimer disease. A mutation in this gene was found in individuals with dementia with Lewy bodies. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
|
Digestion Time | 2 min |
| Morphology | Adherent | Passage Ratio | 1:8~1:10 |
| Complete Culture Medium | IMDM+10%FBS | Freezing Medium | 90%FBS+10%DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
FAQ
Which is better for studying SNCB function, SNCB Knockout HAP1 Cell Line or SNCB overexpression HAP1 Cell Line?
The choice depends on whether you are studying β-synuclein's role as a presynaptic protein or its emerging functions in modulating α-synuclein aggregation in neurodegenerative disease contexts. The Knockout line is appropriate for asking whether β-synuclein is required for specific cellular phenotypes, but note that physiological β-synuclein function is principally in neurons — HAP1 is most informative for biochemical and interactome studies. Overexpression is useful for studying β-synuclein's reported neuroprotective effect against α-synuclein toxicity in heterologous expression contexts.
For synuclein research, the EDITGENE SNCB Knockout in HAP1 is most useful for in vitro biochemistry and rescue with engineered β-synuclein variants in a clean genetic background. For neurodegenerative disease modeling, neuronal cell systems (SH-SY5Y, H4, primary neurons) are more appropriate. Rescue with wild-type or aggregation-promoting variants enables mechanistic dissection.
Is this SNCB Knockout HAP1 Cell Line compatible with overexpression rescue experiments?
Yes. β-synuclein rescue experiments require attention to its small protein architecture:
• Construct design: use a codon-modified SNCB sequence with a small N-terminal tag (HA, FLAG); C-terminal tags can interfere with the highly acidic C-terminus that mediates protein-protein interactions.
• Membrane binding-deficient rescue: N-terminal amphipathic α-helix mutations affecting membrane binding can dissect membrane-associated versus cytosolic functions.
• α-synuclein interaction studies: rescue followed by co-expression with α-synuclein enables direct study of β-synuclein's reported neuroprotective interaction.
• Disease variant rescue: V70M and P123H variants associated with dementia with Lewy bodies enable disease modeling.
HAP1-specific considerations:
• Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay.
• Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended.
• Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.